Psychedelic therapy: a roadmap for wider acceptance and utilization

Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer

(2020) Gabrielle I Agin-Liebes et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

(2020) Alan K. Davis et al.   JAMA Psychiatry

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

(2019) Michael C. Mithoefer et al.   PSYCHOPHARMACOLOGY

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

(2018) Matthew W. Johnson et al.   NEUROPHARMACOLOGY

Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature

(2018) Timothy I. Michaels et al.   BMC Psychiatry

Psilocybin for treating substance use disorders?

(2016) Bas T.H. de Veen et al.   Expert Review of Neurotherapeutics

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin for treating substance use disorders?

(2016) Bas T.H. de Veen et al.   Expert Review of Neurotherapeutics

Harm potential of magic mushroom use: A review

(2011) Jan van Amsterdam et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY